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Introduction
Oral squamous cell carcinoma (OSCC) is known to have a potent activity of local invasion. Its invasion into the adjoining maxilla and mandible, in particular, is a major clinical problem. 1, 2 While gingival and oral floor carcinoma are frequently associated with mandibulectomy the extent of bone invasion can only be assessed by diagnostic imaging. It has been pointed out that resection of the maxilla and mandible occasionally amounts to oversurgery. In recent years, it has been reported that osteoclast associated with bone invasion and metastasis to the bone by cancer cells is mediated by osteoclasts rather than being directly caused by cancer cells (i.e., osteoclastic bone resorption). 3 We have carried out immunohistological analysis using specimens obtained from oral squamous cell carcinoma patients following mandibulectomy. 4 The results of these analytical studies have demonstrated in particular, that the presence of the osteoclast activation factors interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and parathyroid hormone-related protein (PTHrP) have a strong involvement in this process. 5 In this study, we have prepared a murine model of mandibular invasion by cancer cells and investigated the presence of the osteoclast activation factors IL-6, TNF-α, and PTHrP in order to shed light on the mechanism of bone invasion by OSCC.
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Materials and Methods
Cell culture. The SCCVII used in this study is an established cell strain derived from OSCC on the oral floor in mice. 6 It has been reported both as a model for distant metastasis and as a model for salivary gland tumor transplanted to the submandibular gland. Treatment was given for 3 weeks. On days 1, 7, and 14, the mice were weighed and the longest diameter of the mass in the buccal region was measured in three directions. At the end of week 3, all surviving mice were sacrificed. The tumors were resected and preserved at -70°C, and the heads of the mic e were fixed in 10% formalin (Wako Pure Chemical Industries, Ltd., Osaka, Japan).
The specimens were analyzed by (1) three-dimensional imaging using micro-computed tomography (micro-CT), (2) histopathological observation using Hematoxylin -Eosin (H-E) staining and Tartrate-Resistant Acid Phosphatase (TRAP) staining, and (3) confirmation of mRNA expression of the osteoclast-related cytokines IL-6, TNF-α, and PTHrP.
Micro-computed tomography (CT) and 3-dimensional reconstruction.
The head and neck of the mice was imaged with a micro-CT (ultra-micro focus X ray CT unit KMS-755, Kashimura, Osaka, Japan), at a minimum tomographic width of 20 -30µm. The imaging conditions were: lamp 7 voltage 45.0kV, lamp current 100.0µA, multiplying factor 2.0. After preparing two-dimensional slice data from the resulting images by the back projection method, a steric image was constructed with 3 -dimensional reconstruction software (TRI/3D Bon; R2.1.16-S Ratoc, Tokyo, Japan).
Hematoxylin-eosin (H-E) staining and tartrate-resistant acid
phosphatase (TRAP) staining. After subsequent decalcification with 10% formalin formate, the frontal sections of the occipital region were embedded in paraffin by the routine method to prepare thin slices for microscopy using a H-E double-stain.
After decalcification with a 10% aqueous solution of EDTA, paraffin-embedded specimens were prepared and TRAP staining was performed using a TRAP Kit (Hokudo Co., Sapporo, Japan) and Mayer's hematoxylin (Mutoo Pure Chemicals Ltd., Tokyo, Japan).
Preparation of mRNA and semiquantative RT-PCR. Specimens were taken from the SCCVII cultured cells as well as from the injected portions of the mice in the control group and the SCCVII transplanted group for RNA isolation using the AGPC method. After heating for five minutes, 1µg of the RNA sample was mixed with the reverse transcriptase solution to synthesize cDNA. The reaction took place at 30°C for 60 minutes.
IL-6, TNF-α, and PTHrP were then amplified by the PCR method and the 
Results
During the 3 weeks of treatment, 12 mice survived. In our bone invasion models, tumors usually grew for about 3-4 weeks and died after that (Fig   1) . Body weights changed in each group during the initial three weeks.
Compared with the control, the body weights of SCCVII transplanted group tended to decrease (Fig 2) . The differences in tumor size were significant between the two groups. The tumors transplanted into the SCCVII transplanted group of mice grew rapidly. Mean tumor diameter was 2263.1mm 3 in the SCCVII transplanted group after 3 weeks (Fig 1,2) .
Three-dimensional image analysis using micro -CT. Micro-CT showed bone invasion only in the SCCVII transplanted group. Anatomical observation of the maxilla and mandible using the micro-CT revealed an inclination of the teeth and bone resorption in the mandibular angle, on the surface of the mandible and in the zygomatic arch, being different from the ordinary facial bones. The mandibles were obviously asymmetric, and the zygomas were bowed (Fig 3) .
Appearance of resorption in the mandibular bone. The histopathologic findings obtained with H-E staining indicated that the tumor cells in the mandible of all animals of the SCCVII transplanted group exhibited funicular invasion and presented a serrated pattern of bone resorption (Fig   4) . The TRAP stain findings showed evidence of accumulated osteoclasts in considerable numbers around the mandible (Fig 5) .
Expression of the osteoclast-related cytokine mRNA. It has been
confirmed that SCCVII cells express IL-6, TNF-α, and PTHrP at the mRNA level. Similarly, tumors of the SCCVII transplanted mice showed mRNA expression of IL-6, TNF-α, and PTHrP. In contrast, the control group showed no evidence of expression (Fig 6) . This makes it clear that the newly established murine model of invasive OSCC closely reflects the clinical features of human invasive OSCC and is thus useful in shedding light on the mechanism of bone invasion. Given that IL-6, TNF-α, and
PTHrP are involved in the same manner as in humans it can be surmised that bone resorption is mediated by the cytokines produced by the tumor cells.
Discussion
Animal models are essential for studies of the mechanism of bone invasion by OSCC. SCCVII is a malignant tumor cell line derived from the mouse and grows without being affected by the immune system. 6, 7 This cell line was first used to develop an animal model of oral cancer of the oral floor. osteoclasts not only i n the H-E but also in the TRAP stained specimens.
This was clear evidence of the fact that bone resorption was osteoclast-mediated. The present experimental setup can thus be evaluated as being extremely useful as a bone invasion model that closely reflects the clinical features.
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In human invasive OSCC the tumor cells are known to show a strong expression of IL-6, TNF-α, and PTHrP. 2, 3, 8 In our animal models, it was possible to confirm the expression of these cytokines from the SCCVII cultured cells at the mRNA level. Roughly the same results (i.e., enhanced expression of all cytokines at the mRNA level) were also obtained with neoplastic tumor tissues that had been transplanted. This substantiates the fact that the SCCVII cell strains are also subject to the influence of the osteoclast-related cytokines.
Much of the significant progress made in the determination of the bone invasion mechanism is due to the recent spectacular advances in the basic study of bone metabolism. 8, 9 The isolation and identification of the PTHrP, the causal factor of hypercalcemia associated with cancer, in particular, was a milestone in the development of research on bone metastasis and bone invasion by cancer cells. 9 Okamoto et al. produced evidence in their in -vitro study that IL-6 is involved in the bone invasion of OSCC. 2 Recently, it has been clarified that the differentiation and functions of osteoclasts are strictly controlled by the RANKL expressed on the cell membranes of the osteoblasts or marrow interstitial cells. 10 We, for our part, have carried out immunohistochemical analyses on various osteoclast related cytokines, and have been able to demonstrate the possibility that IL-6, TNF-α, and PTHrP may be involved at least in bone invasion by human gingival cancer. 3, 5 In much the same manner it has also been possible, in our present study with the SCCVII cell strain, to substantiate the production of these cytokines and their involvement in bone invasion and in causing the formation of osteoclasts in large numbers.
The use of the animal model may provide a means of shedding light on the mechanism by which OSCC with the potential for cytokine production causes bone invasion.
There is no doubting the fact that the clarification of the cytokine network is strategically most important in establishing a method for the diagnosis and treatment of bone invasion by gingival cancer. The preoperative testing of biopsy samples to determine the extent to which cytokines are present is likely to become, in the foreseeable future, a therapy planning approach that is consistent with the principles of evidence-based medicine.
In any event, however, these studies make use of animal models related to bone invasion, but the bone invasion model involving the cell transplantation of OSCC has been established only at our Department. It is our understanding that this model reflects the clinical features most closely and is thus most effective and useful in elucidating the invasion mechanism and in clarifying the treatment method. In this context we would like to emphasize that the determination of the mechanism of bone 13 invasion in the oral cancer domain in fuller detail is bound to substantially benefit the further progress of dental medicine. 11, 12 In the future, it will be necessary to investigate the expression of cytokines and calcium in the serum in fuller detail at the protein level. It is also felt essential for progress studying research and in the interest of developing new methods for cancer therapy targeting the osteoclast activatin g factors to introduce antisense oligonucleotides of the respective cytokines in this cell strain to inhibit the expression of these cytokines and investigate their involvement in bone invasion and suppress bone invasion through the administration of their antibodies and bone resorption inhibitors.
